The role of mitochondrial genomics in patients with non-alcoholic steatohepatitis (NASH)
- PMID: 27596100
- PMCID: PMC5011877
- DOI: 10.1186/s12881-016-0324-0
The role of mitochondrial genomics in patients with non-alcoholic steatohepatitis (NASH)
Abstract
Background: Visceral obesity and metabolic syndrome are commonly associated with non-alcoholic fatty liver disease (NAFLD). The progression of steatosis to NASH depends on a number of metabolic and patient-related factors. The mechanisms of genetic predisposition towards the development of NASH and related fibrosis remain unclear. In this study, our aim was to utilize mitotyping and identify mitochondrial haplotypes that may be associated with NAFLD.
Methods: We examined mitochondrial haplotypes along with patatin-like phospholipase domain containing 3 (PNPLA3) rs738409 genotype to determine their association with NAFLD phenotypes. Whole blood samples were obtained from 341 patients (BMI > 35) undergoing weight reduction surgery after written consent. Liver biopsies were centrally reviewed by a single pathologist based on predetermined pathologic protocol (41.9 % Non-NASH NAFLD, 30.4 % NASH, 27.5 % controls). A 1,122 bp of the mitochondrial control loop was sequenced for each sample and classified into haplogroups.
Results: The presence of haplogroup L exhibits protection against the development of NASH and pericellular fibrosis. The alleles of PNPLA3 locus showed differential distribution in cohorts with NAFLD, NASH and pericellular fibrosis. Heterozygosity at this locus is independently associated with higher risk of having NASH and pericellular fibrosis.
Conclusion: Mitochondrial genetics play an important role in NASH probably by modulation of oxidative stress and the efficiency of oxidative phosphorylation.
Keywords: Ethnicity; Hepatic fibrosis; Obesity; PNPLA3 rs738409.
Figures


Similar articles
-
PNPLA3 genotype increases susceptibility of nonalcoholic steatohepatitis among obese patients with nonalcoholic fatty liver disease.Surg Obes Relat Dis. 2015 Jul-Aug;11(4):888-94. doi: 10.1016/j.soard.2014.07.016. Epub 2014 Aug 1. Surg Obes Relat Dis. 2015. PMID: 25240529
-
Validation of PNPLA3 polymorphisms as risk factor for NAFLD and liver fibrosis in an admixed population.Ann Hepatol. 2019 May-Jun;18(3):466-471. doi: 10.1016/j.aohep.2018.10.004. Epub 2019 Apr 18. Ann Hepatol. 2019. PMID: 31054980
-
Association of single nucleotide polymorphism at PNPLA3 with fatty liver, steatohepatitis, and cirrhosis of liver.Indian J Gastroenterol. 2017 Sep;36(5):366-372. doi: 10.1007/s12664-017-0784-y. Epub 2017 Oct 4. Indian J Gastroenterol. 2017. PMID: 28975533
-
Molecular Mechanisms: Connections between Nonalcoholic Fatty Liver Disease, Steatohepatitis and Hepatocellular Carcinoma.Int J Mol Sci. 2020 Feb 23;21(4):1525. doi: 10.3390/ijms21041525. Int J Mol Sci. 2020. PMID: 32102237 Free PMC article. Review.
-
Association between patatin-like phospholipase domain containing 3 gene (PNPLA3) polymorphisms and nonalcoholic fatty liver disease: a HuGE review and meta-analysis.Sci Rep. 2015 Mar 20;5:9284. doi: 10.1038/srep09284. Sci Rep. 2015. PMID: 25791171 Free PMC article. Review.
Cited by
-
Mitochondrial Mutations and Genetic Factors Determining NAFLD Risk.Int J Mol Sci. 2021 Apr 24;22(9):4459. doi: 10.3390/ijms22094459. Int J Mol Sci. 2021. PMID: 33923295 Free PMC article. Review.
-
Nonalcoholic Fatty Liver Disease (NAFLD). Mitochondria as Players and Targets of Therapies?Int J Mol Sci. 2021 May 20;22(10):5375. doi: 10.3390/ijms22105375. Int J Mol Sci. 2021. PMID: 34065331 Free PMC article. Review.
-
Adipose tissue and the physiologic underpinnings of metabolic disease.Surg Obes Relat Dis. 2018 Nov;14(11):1755-1763. doi: 10.1016/j.soard.2018.07.032. Epub 2018 Aug 7. Surg Obes Relat Dis. 2018. PMID: 30193906 Free PMC article. Review.
-
Non-alcoholic Steatohepatitis in Asians: Current Perspectives and Future Directions.Cureus. 2023 Aug 2;15(8):e42852. doi: 10.7759/cureus.42852. eCollection 2023 Aug. Cureus. 2023. PMID: 37664266 Free PMC article. Review.
-
The effect of hydroalcoholic Berberis integerrima fruits extract on the lipid profile, antioxidant parameters and liver and kidney function tests in patients with nonalcoholic fatty liver disease.Saudi J Biol Sci. 2020 Aug;27(8):2031-2037. doi: 10.1016/j.sjbs.2020.04.037. Epub 2020 Apr 25. Saudi J Biol Sci. 2020. PMID: 32742180 Free PMC article.
References
-
- Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, Charlton M, Sanyal AJ. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American association for the study of liver diseases, American College of gastroenterology, and the American gastroenterological association. Hepatology. 2012;55:2005–2023. doi: 10.1002/hep.25762. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical